AXSOME THERAPEUTICS, INC. Finance Lease, Right-of-Use Asset, Amortization
AXSOME THERAPEUTICS, INC. (AXSM) reported Finance Lease, Right-of-Use Asset, Amortization of $1.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $1.16M, a 115.08% increase year-over-year.
- AXSOME THERAPEUTICS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $679.00K, a 64.81% increase year-over-year.
- AXSOME THERAPEUTICS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $553.00K, a 64.09% increase year-over-year.
- AXSOME THERAPEUTICS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $684.00K, a 111.11% increase year-over-year.
- AXSOME THERAPEUTICS, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $2.19M, a 111.41% increase from fiscal 2024.
- AXSOME THERAPEUTICS, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $1.03M.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.16M 10-Q · filed 2026-08-10 | $1.83M 10-Q · filed 2026-08-10 | $2.39M derived: sum of 3 quarters · filed 2026-08-10 | $3.07M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $679.00K 10-Q · filed 2026-05-04 | $1.23M derived: sum of 2 quarters · filed 2026-05-04 | $1.92M derived: sum of 3 quarters · filed 2026-05-04 | $2.45M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $553.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.24M derived: sum of 2 quarters · filed 2026-02-23 | $1.77M derived: sum of 3 quarters · filed 2026-08-10 | $2.19M 10-K · filed 2026-02-23 |
| 2025-09-30 | $684.00K 10-Q · filed 2025-11-03 | $1.22M derived: sum of 2 quarters · filed 2026-08-10 | $1.63M 10-Q · filed 2025-11-03 | $1.97M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $537.00K 10-Q · filed 2026-08-10 | $949.00K 10-Q · filed 2026-08-10 | $1.29M derived: sum of 3 quarters · filed 2026-08-10 | $1.61M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $412.00K 10-Q · filed 2026-05-04 | $749.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.07M derived: sum of 3 quarters · filed 2026-05-04 | $1.34M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $661.00K derived: sum of 2 quarters · filed 2026-02-23 | $924.00K derived: sum of 3 quarters · filed 2026-02-23 | $1.03M 10-K · filed 2026-02-23 |
| 2024-09-30 | $324.00K 10-Q · filed 2025-11-03 | $587.00K derived: sum of 2 quarters · filed 2025-11-03 | $697.00K 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $263.00K 10-Q · filed 2025-08-04 | $373.00K 10-Q · filed 2025-08-04 | ||
| 2024-03-31 | $110.00K 10-Q · filed 2025-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |